Why the study?
Does d-sotalol decrease defibrillation energy requirements in patients undergoing automatic defibrillator implantation?
Does d-sotalol decrease defibrillation energy requirements in patients undergoing automatic defibrillator implantation?
d-Sotalol significantly lowers defibrillation energy and voltage requirements in humans, potentially increasing the safety margin for patients with implanted defibrillators.
No takes yet. Share an insight, caveat, or question.
May reduce defibrillation thresholds in ICD patients; hypothesis-generating and requires randomized confirmation before practice change.
DORIAN et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: